financetom
Business
financetom
/
Business
/
Etsy Q1 Earnings Decline, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Etsy Q1 Earnings Decline, Revenue Rises
May 2, 2024 1:06 AM

03:39 AM EDT, 05/02/2024 (MT Newswires) -- Etsy ( ETSY ) reported Q1 net income late Wednesday of $0.48 per diluted share, down from $0.53 a year earlier.

Analysts polled by Capital IQ expected GAAP EPS of $0.49.

Revenue for the quarter ended March 31 was roughly $646 million, up from $640.9 million a year ago.

Analysts surveyed by Capital IQ expected $646.5 million.

Price: 61.60, Change: -8.14, Percent Change: -11.67

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Aug 20, 2024
08:57 AM EDT, 08/20/2024 (MT Newswires) -- Consumer stocks were flat to higher pre-bell Tuesday as the Consumer Staples Select Sector SPDR Fund (XLP) was unchanged and the Consumer Discretionary Select Sector SPDR Fund (XLY) was recently up 0.3%. Vipshop Holdings ( VIPS ) shares fell 6% after the company reported lower Q2 non-GAAP earnings and revenue. ...
Bio-Rad Laboratories Names Jon DiVincenzo COO
Bio-Rad Laboratories Names Jon DiVincenzo COO
Aug 20, 2024
08:50 AM EDT, 08/20/2024 (MT Newswires) -- Bio-Rad Laboratories ( BIO/B ) said Tuesday that it has appointed Jon DiVincenzo as chief operating officer, effective Sept. 9, to succeed Andy Last, who is set to retire. Most recently, DiVincenzo was president of Central Laboratories and International at Labcorp Holdings (LH). Price: 328.49, Change: +2.16, Percent Change: +0.66 ...
Sarepta Therapeutics Insider Bought Shares Worth $4,955,728, According to a Recent SEC Filing
Sarepta Therapeutics Insider Bought Shares Worth $4,955,728, According to a Recent SEC Filing
Aug 20, 2024
08:50 AM EDT, 08/20/2024 (MT Newswires) -- Michael Andrew Chambers, Director, on August 16, 2024, executed a purchase for 37,038 shares in Sarepta Therapeutics ( SRPT ) for $4,955,728. Following the Form 4 filing with the SEC, Chambers has control over a total of 292,311 shares of the company, with 8,277 shares held directly and 284,034 controlled indirectly. SEC Filing:...
Oroco Resource Details Economic Study for Santo Tomas Project in Mexico
Oroco Resource Details Economic Study for Santo Tomas Project in Mexico
Aug 20, 2024
08:51 AM EDT, 08/20/2024 (MT Newswires) -- Oroco Resource ( ORRCF ) on Tuesday released the results of a preliminary economic assessment on the North and South zones of its Santo Tomas porphyry copper project in Mexico. The study outlined a posttax net present value of US$1.48 billion based on an 8% discount rate, with a 22.2% internal rate of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved